"A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality of life for the majority of patients. […] This trial opens the door to develop similar cellular immunotherapies for certain other autoimmune conditions."
https://www.technologynetworks.com/...ific-t-cell-therapy-for-progressive-ms-312073
https://www.technologynetworks.com/...ific-t-cell-therapy-for-progressive-ms-312073